Replies to post #414720 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

NONSENSE!!!

[kevindenver]

For Alzheimer's disease, blarcamesine will be granted an Accelerated Approval with no need for another P3 precision medicine formated trial, only a follow up P4 for confirmation.

I do believe the precision model will be utilized for patient selection in other planned trial indications.